Minimization of immunosuppression: Transplant immunology
- 30 November 2008
- journal article
- Published by Elsevier BV in Transplant Immunology
- Vol. 20 (1-2), 48-54
- https://doi.org/10.1016/j.trim.2008.10.001
Abstract
No abstract availableThis publication has 43 references indexed in Scilit:
- Outcome of Heart Transplants 15 to 20 Years Ago: Graft Survival, Post-transplant Morbidity, and Risk Factors for MortalityThe Journal of Heart and Lung Transplantation, 2008
- Registry of the International Society for Heart and Lung Transplantation: Twenty-fourth Official Adult Heart Transplant Report—2007The Journal of Heart and Lung Transplantation, 2007
- Tacrolimus in Heart Transplant RecipientsBioDrugs, 2007
- The Need for a Tailored Immunosuppression in Older Heart Transplant RecipientsThe Journal of Heart and Lung Transplantation, 2005
- To induce or not to induce: Do patients at greatest risk for fatal rejection benefit from cytolytic induction therapy?The Journal of Heart and Lung Transplantation, 2005
- Prevention of Rejection in Cardiac Transplantation by Blockade of the Interleukin-2 Receptor with a Monoclonal AntibodyThe New England Journal of Medicine, 2000
- Neoral versus sandimmun: clinical impact and modification of immunosuppressive therapy in cardiac transplantationTransplantation Proceedings, 1998
- Long-term safety and efficacy of neoral in heart transplantationTransplantation Proceedings, 1998
- A RANDOMIZED ACTIVE-CONTROLLED TRIAL OF MYCOPHENOLATE MOFETIL IN HEART TRANSPLANT RECIPIENTS1Transplantation, 1998
- TACROLIMUS AS A RESCUE IMMUNOSUPPRESSANT AFTER HEART AND LUNG TRANSPLANTATION1Transplantation, 1998